INFLIXIMAB TROUGH LEVELS IN THE INDUCTION PHASE ARE ASSOCIATED WITH PROLONGED REMISSION IN CROHN´S DISEASE PATIENTS.

María Dolores Martín-Arranz  1     Marta Jaquotot Herranz  2     Eduardo Martín-Arranz  2     Ana Martínez Feito  3     Mariana Díaz-Almirón  4     Cristina Suárez Ferrer  2     Joaquin Poza Cordon  5     Silvia Gómez Senent     Laura García Ramirez     Mezcua Perez Aracelia     Dora Pascual-Salcedo    
1 La Paz,Gastroenterology,Madrid,Spain
2 University Hospital La Paz,Gastroenterology,MADRID,Spain
3 IdiPaz,Inmunology,MADRID,Spain
4 University Hospital La Paz,Bioestadistics,MADRID,Spain
5 University Hospital La Paz,Gastroen

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing